| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BioAtla, Inc. | Director | Common Stock | 52,307 | $22,492 | $0.4300 | 18 Jun 2025 | Direct |
| RayzeBio, Inc. | CHIEF MEDICAL OFFICER | Common Stock | 0 | $0 | $62.50 | 26 Feb 2024 | Direct |
| Tyra Biosciences, Inc. | Director | Stock Option (Right to Buy) | 22,200 | 29 May 2025 | Direct | ||
| CRESCENT BIOPHARMA, INC. | Director | Stock Option (Right to Buy) | 9,023 | 23 Jun 2025 | Direct | ||
| RayzeBio, Inc. | CHIEF MEDICAL OFFICER | Employee Stock Option (right to buy) | 0 | 26 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CBIO | GLYCOMIMETICS INC | 23 Jun 2025 | 1 | $0 | 4 | Director | 23 Jun 2025, 18:51 |
| BCAB | BioAtla, Inc. | 18 Jun 2025 | 1 | $0 | 4 | Director | 18 Jun 2025, 19:45 |
| CBIO | GLYCOMIMETICS INC | 13 Jun 2025 | 0 | $0 | 3 | Director | 23 Jun 2025, 18:22 |
| TYRA | Tyra Biosciences, Inc. | 29 May 2025 | 1 | $0 | 4 | Director | 02 Jun 2025, 16:05 |
| BCAB | BioAtla, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 16:13 |
| TYRA | Tyra Biosciences, Inc. | 07 May 2024 | 1 | $0 | 4 | Director | 09 May 2024, 16:49 |
| TYRA | Tyra Biosciences, Inc. | 07 May 2024 | 0 | $0 | 3 | Director | 09 May 2024, 16:49 |
| RYZB | RayzeBio, Inc. | 26 Feb 2024 | 5 | $-20,215,938 | 4 | CHIEF MEDICAL OFFICER | 27 Feb 2024, 16:45 |
| RYZB | RayzeBio, Inc. | 22 Jan 2024 | 2 | $100,035 | 4 | CHIEF MEDICAL OFFICER | 06 Feb 2024, 18:11 |
| RYZB | RayzeBio, Inc. | 17 Nov 2023 | 1 | $0 | 4 | Chief Medical Officer | 17 Nov 2023, 18:36 |
| RYZB | RayzeBio, Inc. | 14 Sep 2023 | 0 | $0 | 3 | Chief Medical Officer | 14 Sep 2023, 20:37 |
| BCAB | BioAtla, Inc. | 14 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 18:41 |
| BCAB | BioAtla, Inc. | 16 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 19:51 |
| BCAB | BioAtla, Inc. | 15 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 21:34 |